Construction and testing of a risk prediction classifier for cardia carcinoma.


Journal

Carcinogenesis
ISSN: 1460-2180
Titre abrégé: Carcinogenesis
Pays: England
ID NLM: 8008055

Informations de publication

Date de publication:
02 12 2023
Historique:
received: 11 05 2023
revised: 19 06 2023
accepted: 21 08 2023
medline: 4 12 2023
pubmed: 25 8 2023
entrez: 25 8 2023
Statut: ppublish

Résumé

This research aimed to construct a prediction model for stages II and III cardia carcinoma (CC), and provide an effective preoperative evaluation tool for clinicians. CC mRNA expression matrix was obtained from Gene Expression Omnibus and The Cancer Genome Atlas databases. Non-negative matrix factorization was used to cluster data to obtain subgroup information, and weighted gene co-expression network analysis was used to uncover key modules linked to different subgroups. Gene-set enrichment analysis analyzed biological pathways of different subgroups. The related pathways of multiple modules were scrutinized with Kyoto Encyclopedia of Genes and Genomes. Key modules were manually annotated to screen CC-related genes. Subsequently, quantitative real-time polymerase chain reaction assessed CC-related gene expression in fresh tissues and paraffin samples, and Pearson correlation analysis was performed. A classification model was constructed and the predictive ability was evaluated by the receiver operating characteristic curve. CC patients had four subgroups that were associated with brown, turquoise, red, and black modules, respectively. The CC-related modules were mainly associated with abnormal cell metabolism and inflammatory immune pathways. Then, 76 CC-elated genes were identified. Pearson correlation analysis presented that THBS4, COL14A1, DPYSL3, FGF7, and SVIL levels were relatively stable in fresh and paraffin tissues. The area under the curve of 5-gene combined prediction for staging was 0.8571, indicating good prediction ability. The staging classifier for CC based on THBS4, COL14A1, DPYSL3, FGF7, and SVIL has a good predictive effect, which may provide effective guidance for whether CC patients need emergency surgery.

Identifiants

pubmed: 37624090
pii: 7250983
doi: 10.1093/carcin/bgad059
doi:

Substances chimiques

Paraffin 8002-74-2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

662-670

Subventions

Organisme : Tianjin Key Medical Discipline (Specialty) Construction Project
ID : TJYXZDXK-009A

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Auteurs

Zhiqiang Liu (Z)

Department of Gastric Surgery, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, P.R. China.
Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, P.R. China.
Tianjin's Clinical Research Center for Cancer, Tianjin 300060, P.R. China.
Department of Gastric Surgery, Anyang Tumor Hospital, Anyang City 455000, P.R. China.
Tianjin Medical University, Tianjin 300070, P.R. China.

Ganshu Xia (G)

Department of Gastric Surgery, Anyang Tumor Hospital, Anyang City 455000, P.R. China.

Xiaolong Liang (X)

Department of Gastric Surgery, Anyang Tumor Hospital, Anyang City 455000, P.R. China.

Shoumiao Li (S)

Department of Gastric Surgery, Anyang Tumor Hospital, Anyang City 455000, P.R. China.

Yanxin Gong (Y)

Department of Gastric Surgery, Anyang Tumor Hospital, Anyang City 455000, P.R. China.

Baozhong Li (B)

Department of Gastric Surgery, Anyang Tumor Hospital, Anyang City 455000, P.R. China.

Jingyu Deng (J)

Department of Gastric Surgery, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, P.R. China.
Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, P.R. China.
Tianjin's Clinical Research Center for Cancer, Tianjin 300060, P.R. China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH